Q32 Bio prices offering including pre-funded warrants at USD 18.2499 each

Q32 Bio Inc

Q32 Bio Inc

QTTB

0.00
  • Q32 Bio priced a $200 million public offering that includes 4,931,506 pre-funded warrants to buy common stock.
  • Pre-funded warrants priced at USD 18.2499 each with a USD 0.0001 per share exercise price; common shares priced at USD 18.25.
  • Offering includes 6,027,399 common shares; underwriters hold a 30-day option for up to 1,643,835 additional shares.
  • Deal expected to close around July 16, 2026; proceeds earmarked for working capital, including R&D and bempikibart development.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Q32 Bio Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202607142258PR_NEWS_USPR_____NE05014) on July 15, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.